Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on topics of interest to Dr. Weyrich that may be of interest to the world wide audience. Due to limitations of time, not all information that Dr. Weyrich knows or would like to further research is published here. Dr. Weyrich welcomes financial contributions to support specific research topics, as well as copies of non-free access journal articles for him to review on a topic. Constructive criticism is also welcome.

Overview of Liver Cancer

This web page discusses liver cancer, which appears to have different mechanisms than breast and prostate cancer.

Please see Cancer Overview for general information that is common to all forms of cancer.

Dr. Weyrich is not an expert in the treatment of cancer, but does offer supportive therapies to reduce pain and nausea, mitigate the side effects, and to generally boost the immune system.

Complimentary and alternative treatments for liver cancer that are considered below include:

  • Low Dose Naltrexone

Etiology of Liver Cancer

[Friedman2013] has presented a compelling model for the prevention and treatment of breast and prostate cancer. An important feature of this model is observation that synthetic (non-bio-identical) estrogens and progestins actually raise the risk of breast and prostate cancer. It appears [Go to cancer.govcancer.gov], that synthetic hormones in oral contraceptives increases the risk of some benign liver cancers, such as hepatocellular adenomas; it is less clear the extent that malignant liver tumors, such as hepatocellular carcinomas, are associated with oral contraceptive use [LaVecchia2006], [Farges2011].

The differences between different types of cancers require further study.

Treatment of Liver Cancer

Please see conventional, complimentary and alternative medical treatments for important background information regarding the different types of medical treatments discussed below.

Naturopathic, Complimentary and Alternative Treatments

Low Dose Naltrexone (LDN)

According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit liver cancer. [LDN_Cancer] reports that the late Dr. Bernard Bihari treated approximately 450 patients with some form of cancer, with a 60% success rate, almost all of who had failed to respond to standard treatments. In particular, 5 patients with pancreatic cancer metastatic to the liver appeared to be in remission.

Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN). However, Dr. Weyrich has not treated any cases of liver cancer with LDN.

Please see What is Low Dose Naltrexone? for more information.

References for Liver Cancer